Trial intelligence / Profile preview

Celecoxib versus acetaminophen as pre-emptive analgesia after impacted mandibular third molar surgery

IRCT20230714058773N4Phase 2Completed

Sponsor
Armed Forces Institute of Dentistry
Start
Jun 2020
Modality
Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 2 trial of celecoxib and acetaminophen in postoperative pain (2 arms), sponsored by Armed Forces Institute of Dentistry. Primary endpoints: Mean postoperative pain score at 4 hours, Mean postoperative pain score at 6 hours and 2 more. Started Jun 2020; status: completed.

02

Drugs

celecoxibacetaminophen
03

Conditions

postoperative pain

Beyond the preview

Go deeper on IRCT20230714058773N4.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20230714058773N4.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call